High-frequency episodic migraine: Time for its recognition as a migraine subtype?

Other authors

Institut Català de la Salut

[Cammarota F, De Icco R, Vaghi G, Corrado M, Bighiani F] Department of Brain and Behavioral Sciences, University of Pavia, Pavia, Italy. Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy. [Martinelli D] Headache Science and Neurorehabilitation Unit, IRCCS Mondino Foundation, Pavia, Italy. [Pozo-Rosich P] Unitat de Cefalees, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Grup de Recerca de Cefalea i Dolor Neurològic, Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma of Barcelona, Bellaterra, Spain

Vall d'Hebron Barcelona Hospital Campus

Publication date

2024-12-04T08:23:37Z

2024-12-04T08:23:37Z

2024-10



Abstract

Burden; Classification; Pathophysiology


Carga; Clasificación; Fisiopatología


Càrrega; Classificació; Fisiopatologia


Background High-frequency episodic migraine (HFEM) has gained attention in the field of headache research and clinical practice. In this narrative review, we analyzed the available literature to assess the evidence that could help decide whether HFEM may represent a distinct clinical and/or biological entity within the migraine spectrum. Methods The output of the literature search included 61 papers that were allocated to one of the following topics: (i) socio-demographic features and burden; (ii) clinical and therapeutic aspects; (iii) pathophysiology; and (iv) classification. Results Multiple features differentiate subjects with HFEM from low-frequency episodic migraine and from chronic migraine: education, employment rates, quality of life, disability and psychiatric comorbidities load. Some evidence also suggests that HFEM bears a specific profile of activation of cortical and spinal pain-related pathways, possibly related to maladaptive plasticity. Conclusions Subjects with HFEM bear a distinctive clinical and socio-demographic profile within the episodic migraine group, with a higher disease burden and an increased risk of transitioning to chronic migraine. Recognizing HFEM as a distinct entity is an opportunity for the better understanding of migraine and the spectrum of frequency with which it can manifest, as well as for stimulating further research and more adequate public health approaches.


The authors disclosed receipt of the following financial support for the research, authorship and/or publication of this article: support was provided by the Ministero della Salute (grant number Ricerca Finalizzata GR-2021-12372429).

Document Type

Article


Published version

Language

English

Publisher

SAGE Publications

Related items

Cephalalgia;44(10)

https://doi.org/10.1177/03331024241291578

Recommended citation

This citation was generated automatically.

Rights

Attribution-NonCommercial 4.0 International

http://creativecommons.org/licenses/by-nc/4.0/

This item appears in the following Collection(s)